Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- Hyperhidrosis: postmarketing
- Sweating: postmarketing, 3%
- 5-azacytidine
- Sweating increased: 2.17% - 10.5%
- ACTH(1-39
- Sweating increased: postmarketing
- AMD3100
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Sweating
- Sweating increased
- CAS 76095-16-4
- Hyperhidrosis
- Sweating increased
- CAS 76420-72-9
- Sweating increased: postmarketing
- CGP 19835A
- Hyperhidrosis: very common, 11%
- Cancidas
- Hyperhidrosis
- Sweating: 0% - 3.4%
- Sweating increased: 2.2% - 2.8%
- Enfuvirtide
- FAMP
- Sweating increased: 1% - 13%
- FK463
- Fe(III
- Hyperhidrosis: postmarketing
- Sweating
- Sweating increased
- Forteo
- Sweating: 2.2%
- Sweating increased
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132
- Glat copolymer
- Goserelin
- Hyperhidrosis
- Sweating: 4% - 45%
- Histrelin
- Humalog
- Sweating
- Sweating increased
- ICI 182,780
- Insulin
- Sweating
- Sweating increased
- K779
- Sweating increased: 1% - 21%
- L-Dmp
- Sweating: 1% - 11.8%
- Sweating increased: postmarketing
- LY146032
- Sweating increased: 0% - 5%
- Leuprorelin
- Hyperhidrosis: postmarketing
- Sweating
- Sweating increased
- Lisinopril
- Sweating
- Sweating increased: very rare, postmarketing
- Lovaza
- Lutalyse
- MK-462
- Meropenem anhydrous
- Mersyndol
- Sweating
- Sweating increased
- Metrodin
- N-acetylcysteine
- N-carbamylglutamate
- Hyperhidrosis
- Sweating increased
- Nafarelin
- NovoLog
- Octreotide
- Optison
- Sweating increased: uncommon
- PGE1
- PGE2
- Protirelin
- Refludan
- Stalevo 50
- Supremon
- TlCl
- Triptorelin
- UDCA
- Vitrum
- Zyprexa Relprevv
- acamprosate
- acebutolol
- acetaminophen
- Sweating
- Sweating increased
- acetylcholine
- acitretin
- Sweating increased: postmarketing
- acyclovir
- adenosine
- agomelatine
- alfentanil
- alfuzosin
- allopurinol
- Sweating: postmarketing
- Sweating increased
- almotriptan
- Hyperhidrosis: postmarketing
- Sweating increased: infrequent
- alosetron
- alprazolam
- Sweating: 15.1% - 23.5%
- Sweating increased: frequent
- amantadine
- Sweating increased: postmarketing, uncommon, common
- amiodarone
- amisulpride
- Sweating increased: 0% - 1%
- amitriptyline
- Sweating increased: postmarketing
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B
- Sweating: 7% - 10.8%
- Sweating increased
- anagrelide
- anastrozole
- Sweating: 1% - 6.32%
- Sweating increased
- anthracycline
- Sweating increased: 0% - 12%
- apomorphine
- aprepitant
- Hyperhidrosis
- Sweating increased
- argenine vasopressin
- arginine
- aripiprazole
- arsenic
- arsenic trioxide
- aspirin
- atazanavir
- atenolol
- atomoxetine
- Hyperhidrosis: postmarketing, 4%
- Sweating increased: 4%
- atorvastatin
- atovaquone
- atropine
- azithromycin
- aztreonam
- baclofen
- Hyperhidrosis: uncommon, common
- Sweating
- Sweating increased: uncommon
- benazepril
- benazeprilat
- bendamustine
- benzathine penicillin
- benzphetamine
- bepridil
- betaxolol
- bethanechol
- bexarotene
- Sweating: common, 0% - 6%
- bicalutamide
- bisoprolol
- Sweating
- Sweating increased: 0.7% - 1%
- boceprevir
- bortezomib
- bosentan
- bretylium
- bromcresol green
- Sweating increased: 0% - 3%
- budesonide
- Sweating increased: 5.22% - 17.9%
- bumetanide
- bupivacaine
- Hyperhidrosis
- Sweating increased
- Sweating: postmarketing
- buprenorphine
- Hyperhidrosis: 4%
- Sweating: 12.6% - 14%
- bupropion
- Hyperhidrosis
- Sweating: postmarketing, frequent, 1.6% - 6%
- Sweating increased: 22.3%
- buspirone
- butorphanol
- cabergoline
- Sweating increased: 5.2% - 11.1%
- candesartan
- candesartan cilexetil
- Sweating
- Sweating increased
- capecitabine
- Hyperhidrosis
- Sweating increased: 0.1%
- carbachol
- Sweating
- Sweating increased
- carbamazepine
- Hyperhidrosis: very rare
- Sweating increased: very rare, rare
- carbidopa
- carbinoxamine
- carboprost
- carvedilol
- cefaclor
- cefditoren
- cefpodoxime
- ceftobiprole
- ceftriaxone
- cefuroxime
- celecoxib
- cetirizine
- cevimeline
- Sweating increased: 18.7%
- chloroprocaine
- chlorpheniramine
- cidofovir
- cilazapril
- ciprofloxacin
- Hyperhidrosis: rare
- Sweating: postmarketing, rare
- Sweating increased
- cisplatin
- citalopram
- Sweating
- Sweating increased: 3% - 11.3%
- Hyperhidrosis
- cladribine
- Hyperhidrosis: 3%
- Sweating increased: very common
- clarithromycin
- Hyperhidrosis: postmarketing
- clemastine
- clobazam
- clofarabine
- clomipramine
- Hyperhidrosis
- Sweating: very common
- Sweating increased: 9% - 29%
- clonidine
- clozapine
- codeine
- Sweating
- Sweating increased
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- cyclobenzaprine
- cyclophosphamide
- Hyperhidrosis: postmarketing
- Sweating: 0.1-1%
- Sweating increased
- cyproheptadine
- cyproterone
- cyproterone acetate
- Sweating: common
- Sweating increased
- cytarabine
- Sweating increased: 2.33% - 10.7%
- dabrafenib
- danazol
- dantrolene
- dapagliflozin
- darifenacin
- darunavir
- dasatinib
- deferiprone
- Hyperhidrosis: postmarketing
- degarelix
- delamanid
- delavirdine
- delta 9-THC
- demethyl
- Hyperhidrosis
- Sweating increased
- deprenyl
- Sweating: postmarketing, frequent
- Sweating increased
- desmopressin
- desonide
- desvenlafaxine
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine
- Sweating increased: postmarketing
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- diclofenac
- Sweating
- Sweating increased
- diethylpropion
- diflunisal
- dihydrocodeine
- dihydroergotamine
- Sweating increased: postmarketing, infrequent
- diltiazem
- dimercaprol
- diphenhydramine
- dipyridamole
- disopyramide
- dofetilide
- dolasetron
- donepezil
- Sweating: infrequent
- Sweating increased: frequent
- dorzolamide
- dothiepin
- doxapram
- doxazosin
- Sweating
- Sweating increased: 1% - 1.4%
- doxepin
- Hyperhidrosis: rare
- Sweating
- doxorubicin
- duloxetine
- Hyperhidrosis: 2% - 10%
- Sweating increased
- edrophonium
- efavirenz
- Sweating
- Sweating increased: 0% - 2%
- eletriptan
- entacapone
- Sweating
- Sweating increased: common, 2% - 3.6%
- ephedrine
- epinephrine
- Sweating
- Sweating increased
- eplerenone
- eprosartan
- ergonovine
- eribulin
- ertapenem
- eslicarbazepine acetate
- esmolol
- Hyperhidrosis
- Sweating increased: 9%
- esomeprazole magnesium
- Hyperhidrosis: postmarketing
- Sweating increased
- estazolam
- estradiol
- Hyperhidrosis: postmarketing
- Sweating increased
- etodolac
- etoposide
- etoposide phosphate
- etravirine
- everolimus
- exemestane
- Sweating: 6-19%
- Sweating increased: common, very common, 4.5% - 17.8%
- exenatide
- famciclovir
- febuxostat
- felbamate
- fenofibrate
- fenoldopam
- fenoprofen
- fentanyl
- Hyperhidrosis: 0% - 14.3%
- Sweating: 0% - 4%
- Sweating increased: very rare, postmarketing
- ferumoxytol
- Hyperhidrosis: postmarketing
- Sweating: postmarketing
- flecainide
- fluconazole
- Sweating increased: postmarketing
- fludarabine
- Sweating increased: 0% - 14%
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- Sweating
- Sweating increased
- flunisolide
- flunitrazepam
- fluorescein
- Hyperhidrosis: postmarketing
- fluoxetine
- Sweating: common, 2% - 8.9%
- Sweating increased
- fluphenazine decanoate
- flurazepam
- flurbiprofen
- fluvastatin
- fluvoxamine
- Hyperhidrosis
- Sweating: common, 1% - 7%
- Sweating increased: frequent, 6.9% - 11.2%
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril
- Hyperhidrosis: uncommon
- Sweating increased
- fosinoprilat
- Hyperhidrosis
- Sweating increased
- fosphenytoin
- frovatriptan
- Sweating increased: frequent
- furosemide
- gabapentin
- Sweating: postmarketing, infrequent
- Sweating increased: infrequent
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium
- Hyperhidrosis: postmarketing, 0.9%
- Sweating increased
- gadopentetate
- gadoteridol
- gadoversetamide
- Hyperhidrosis
- Sweating increased
- galantamine
- ganciclovir
- gatifloxacin
- gemcitabine
- gemifloxacin
- glibenclamide
- gliclazide
- glimepiride
- Sweating
- Sweating increased
- glipizide
- glutamine
- Sweating increased: 0% - 12.5%
- glycopyrrolate
- gold sodium thiomalate
- granisetron
- guanfacine
- guanidinium
- haloperidol
- Hyperhidrosis: very rare, postmarketing
- Sweating increased
- hepatitis B vaccines
- histamine
- hydrochlorothiazide
- hydrocodone
- hydromorphone
- Hyperhidrosis: 1.49% - 5.78%
- Sweating
- Sweating increased
- hydroxybutyrate
- Hyperhidrosis: 1% - 3%
- Sweating increased: 0%
- ibandronate
- ibuprofen
- ifosfamide
- Hyperhidrosis: postmarketing
- imatinib
- Sweating: 2.8% - 12.7%
- Sweating increased: uncommon, 0.2% - 14.8%
- imipramine
- Hyperhidrosis: very common
- imiquimod
- Sweating increased: uncommon, 0.1%
- indapamide
- indinavir
- indomethacin
- Hyperhidrosis: 0% - 2%
- Sweating
- insulin detemir
- Hyperhidrosis
- Sweating
- Sweating increased
- iodixanol
- iopamidol
- Sweating
- Sweating increased
- iopromide
- Hyperhidrosis: postmarketing
- Sweating
- Sweating increased
- iotrolan
- ioxaglate
- ioxilan
- ipratropium bromide
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan
- Sweating: 0% - 57%
- Sweating increased
- isocarboxazid
- isomannide
- Sweating
- Sweating increased
- isoproterenol
- isosorbide-5-mononitrate
- Sweating
- Sweating increased
- isradipine
- itraconazole
- Hyperhidrosis
- Sweating increased: 0% - 6%
- ivermectin
- ketoprofen
- ketorolac
- ketorolac tromethamine
- Sweating: postmarketing
- Sweating increased
- labetalol
- Sweating
- Sweating increased: 0% - 1%
- lacosamide
- lamivudine
- Sweating: 1% - 7.6%
- Sweating increased: 5%
- lamotrigine
- Sweating: infrequent, 0% - 2%
- lanreotide
- lansoprazole
- lasofoxifene
- leflunomide
- lenalidomide
- Hyperhidrosis: postmarketing
- Sweating
- Sweating increased: common, 9.92%
- lercanidipine
- Sweating increased: uncommon
- letrozole
- Sweating: 1-22%
- Sweating increased: common, 0.039% - 24.2%
- leuprorelin acetate
- Sweating: 8.33% - 82.5%
- Sweating increased: 12.7% - 79.9%
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- linezolid
- lisdexamfetamine dimesylate
- lisuride
- lomefloxacin
- lomitapide
- lorcaserin
- lormetazepam
- losartan
- lubiprostone
- lurasidone
- magnesium
- maprotiline
- Hyperhidrosis
- Sweating increased
- medroxyprogesterone
- Sweating increased: postmarketing
- medroxyprogesterone acetate
- Sweating
- Sweating increased
- mefloquine
- Hyperhidrosis: postmarketing
- Sweating: postmarketing
- megestrol
- megestrol acetate
- meloxicam
- Hyperhidrosis: 0% - 1.3%
- Sweating
- Sweating increased
- memantine
- meperidine
- mepivacaine
- Sweating
- Sweating increased
- meropenem
- mesna
- Hyperhidrosis
- Sweating increased: 1.7% - 9%
- metaproterenol
- Sweating
- Sweating increased: 0.2% - 1%
- metformin
- methadone
- Sweating
- Sweating increased
- methotrexate
- methylene blue
- Hyperhidrosis
- Sweating
- Sweating increased
- methylergometrine
- methylnaltrexone
- methylphenidate
- Hyperhidrosis: common, 5.1% - 5.7%
- Sweating
- methylprednisolone
- Hyperhidrosis
- Sweating
- Sweating increased
- methylprednisolone sodium succinate
- metoprolol
- Hyperhidrosis: very rare
- Sweating: postmarketing
- Sweating increased: very rare, postmarketing, uncommon
- metronidazole
- mexiletine
- milnacipran
- mirtazapine
- Sweating: postmarketing
- Sweating increased: postmarketing
- misoprostol
- Sweating increased: postmarketing
- mitoxantrone
- Sweating
- Sweating increased: 9%
- moclobemide
- modafinil
- Hyperhidrosis: postmarketing, 1%
- Sweating
- moexiprilat
- morphine
- Sweating
- Hyperhidrosis
- Sweating increased: 2%
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- nabumetone
- nadolol
- nalbuphine
- nalmefene
- naloxone
- naltrexone
- Sweating increased: postmarketing
- naphazoline
- naproxen
- naratriptan
- nateglinide
- Sweating
- Sweating increased
- nefazodone
- nefopam
- nelfinavir
- neostigmine
- Sweating increased: postmarketing
- nesiritide
- niacin
- nicardipine
- Sweating: 1.4%
- Sweating increased: 0.6%
- nicorandil
- nicotine
- nifedipine
- Sweating
- Sweating increased
- nilotinib
- nilutamide
- nimodipine
- nisoldipine
- nitrazepam
- nitrite
- nitroglycerin
- Sweating
- Sweating increased
- nitroprusside
- nizatidine
- norepinephrine
- norfloxacin
- nortriptyline
- Sweating
- Sweating increased
- ofatumumab
- ofloxacin
- olanzapine
- Sweating: postmarketing, infrequent, frequent
- Sweating increased: postmarketing
- olmesartan
- Hyperhidrosis: 0% - 3.45%
- omeprazole
- Hyperhidrosis: postmarketing
- Sweating increased: rare, uncommon
- orlistat
- Sweating increased: uncommon
- ospemifene
- oxaliplatin
- Sweating
- Sweating increased: 0% - 8%
- oxaprozin
- oxcarbazepine
- oxprenolol
- oxycodone
- Hyperhidrosis
- Sweating: 5% - 6%
- oxymorphone
- Sweating increased: 8.6% - 9%
- paclitaxel
- Hyperhidrosis
- Sweating increased
- pamidronate
- pantoprazole
- Sweating
- Sweating increased
- paraldehyde
- parecoxib
- paricalcitol
- paroxetine
- Hyperhidrosis: postmarketing
- Sweating: postmarketing, uncommon, common, 0% - 14%
- Sweating increased: very rare, postmarketing
- pazopanib
- penbutolol
- penicillin
- pentazocine
- Sweating
- Sweating increased
- pentosan polysulfate
- Sweating
- Sweating increased: 1%
- pentostatin
- Sweating: 8% - 21%
- Sweating increased: 8% - 21%
- pentoxifylline
- pergolide
- perhexiline
- perindopril
- perindopril erbumine
- phendimetrazine
- phenelzine
- phenylephrine
- phenytoin
- pilocarpine
- pimozide
- Hyperhidrosis: postmarketing
- Sweating
- pindolol
- pioglitazone
- piperacillin
- piroxicam
- pomalidomide
- Hyperhidrosis: 5.61% - 16.1%
- ponatinib
- posaconazole
- Sweating increased: 1.91% - 9.62%
- pramipexole
- Hyperhidrosis: 1.6%
- Sweating
- pravastatin
- prazosin
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin
- Hyperhidrosis
- Sweating: infrequent
- prilocaine
- procaine
- procarbazine
- Sweating
- Sweating increased
- progesterone
- propafenone
- Sweating increased: 0.3% - 1.4%
- propericiazine
- propofol
- prostacyclin
- pyridostigmine
- quetiapine
- Hyperhidrosis: 2%
- Sweating: frequent, 2%
- quinapril
- quinaprilat
- quinidine
- rabeprazole
- raloxifene
- raltegravir
- raltitrexed
- ramipril
- Sweating
- Sweating increased
- ramiprilat
- ranitidine
- ranolazine
- rapamycin
- rasagiline
- reboxetine
- Hyperhidrosis: 12.1%
- Sweating
- regadenoson
- remifentanil
- retigabine
- retinoic acid
- Sweating: postmarketing
- Sweating increased: 20%
- ribavirin
- Hyperhidrosis: common
- Sweating increased: common, 5% - 41%
- rifapentine
- rifaximin
- riluzole
- rimantadine
- rimonabant
- risperidone
- Sweating
- Sweating increased: infrequent
- ritonavir
- rivastigmine
- Hyperhidrosis: uncommon, common, 2%
- Sweating: uncommon
- Sweating increased: common, frequent, 2% - 4%
- rizatriptan
- ropinirole
- Hyperhidrosis: 3%
- Sweating increased: 1.4% - 7%
- ropivacaine
- Sweating increased: 0.4% - 1.3%
- rotigotine
- Hyperhidrosis: 1% - 3%
- Sweating increased
- salbutamol
- Sweating: 1%
- Sweating increased
- salmon calcitonin acetate
- Sweating increased: postmarketing
- samarium
- saquinavir
- scopolamine
- sertraline
- Sweating
- Sweating increased: postmarketing, common, 3% - 11%
- sibutramine
- sildenafil
- sodium
- sodium ferric gluconate
- sodium iothalamate
- sodium nitroprusside
- sotalol
- Hyperhidrosis: 4.9% - 5.2%
- sparfloxacin
- stavudine
- sulindac
- Sweating
- Sweating increased
- sumatriptan
- Sweating: rare, frequent, 0.6% - 2%
- tacrolimus
- Sweating
- Sweating increased: common
- Hyperhidrosis
- tadalafil
- Hyperhidrosis: postmarketing
- Sweating: postmarketing
- tamoxifen
- tamsulosin
- tapentadol
- tegaserod
- telavancin
- telithromycin
- telmisartan
- Hyperhidrosis: rare, uncommon
- Sweating increased: postmarketing, uncommon
- temazepam
- temozolomide
- Sweating increased: uncommon
- teniposide
- tenofovir
- tenofovir disoproxil fumarate
- terazosin
- terbutaline
- testosterone
- Hyperhidrosis: postmarketing, 1.31%
- Sweating: postmarketing
- Sweating increased
- testosterone undecanoate
- tetrabenazine
- thalidomide
- thiamine
- thioridazine
- Sweating increased: postmarketing
- thiothixene
- thyroxine
- Sweating
- Sweating increased
- tiagabine
- tiaprofenic acid
- tigecycline
- timolol
- tinidazole
- tirofiban
- tizanidine
- tolcapone
- Sweating
- Sweating increased: 4%
- topiramate
- Sweating increased: 1% - 2%
- topotecan
- toremifene
- Sweating: postmarketing, 17% - 20%
- tramadol
- Sweating: common, 4.2% - 9%
- Sweating increased: postmarketing, 0.463% - 7.44%
- trametinib
- trandolapril
- Hyperhidrosis
- Sweating: postmarketing
- trandolaprilat
- tranylcypromine
- trazodone
- Hyperhidrosis: infrequent
- Sweating: 1.4%
- triamcinolone
- triamcinolone acetonide
- triazolam
- tropicamide
- trospium chloride
- trovafloxacin
- v 1784
- Sweating increased: postmarketing
- valdecoxib
- valganciclovir
- valproate
- Sweating
- Sweating increased
- vardenafil
- varenicline
- Hyperhidrosis: uncommon, frequent
- vasopressin
- venlafaxine
- Sweating: postmarketing, common, 1% - 19.3%
- verapamil
- Sweating: postmarketing
- Sweating increased
- vernakalant
- verteporfin
- vilazodone
- vildagliptin
- vincristine
- vinflunine
- vitamin K
- Sweating
- Sweating increased
- voriconazole
- zalcitabine
- zaleplon
- ziconotide
- zidovudine
- Sweating: rare
- Sweating increased: 5%
- zidovudine/lamivudine
- Sweating: 6.3% - 7.6%
- Sweating increased
- ziprasidone
- Sweating: 0% - 2%
- Sweating increased
- zoledronic acid
- Hyperhidrosis: common, 2% - 2.6%
- Sweating increased: postmarketing, uncommon
- zolmitriptan
- Sweating: infrequent, 0% - 3%
- zolpidem
- Hyperhidrosis: postmarketing, rare
- Sweating increased: infrequent
- zonisamide
- zopiclone
- zuclopenthixol
- Hyperhidrosis
- Sweating
- Sweating increased
|
Drugs with this indication
|